Stockholders' Equity - Additional Information - Stock Options (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Stockholders Equity [Line Items]
Options outstanding, intrinsic value	$ 13,892,675	$ 1,149,021
Options exercisable, intrinsic value	9,946,072	432,248
Stock-based compensation expense	740,824	$ 1,171,885
Unvested share-based awards	$ 1,200,000
Expected weighted average period to recognize unearned stock-based compensation	2 years
Stock Options [Member]
Schedule Of Stockholders Equity [Line Items]
Weighted-average grant-date fair value	$ 2.84	$ 1.01